drugset / Trial / NCT00788229

Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

NCT00788229 ↗

Phase 2 Completed 72 enrolled Dhp Korea Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether artificial tears are safe and effective in the treatment of Dry Eye Syndrome.

Timeline

Start
2008-11
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AT02 Monoclonal antibody — Other
Subject AT03 Protein / enzyme biologic — Other
Subject IODINE I124 EVUZAMITIDE Diagnostic / imaging agent — Other

Indications